Skip to main content

The Evaluation of Clinical Prognostic Factors in Osteosarcomas

  • Conference paper
Recent Advances in Musculoskeletal Oncology

Abstract

During the past 15 years, dramatic changes have been made in the treatment of osteosarcoma. The survival rate of patients with osteosarcoma has improved as a result of better adjuvant chemotherapeutic regimens [1–3]. There are many other factors, however, that have been shown to influence the prognosis of this disease, among them the patient’s age, site and size of the lesion, chemotherapeutic regimens, and surgical procedures [4–9]. We recently reviewed all cases of conventional osteosarcoma treated at Chiba Cancer Center, and analyzed the clinical prognostic factors of this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Umeda T, Takada N (1985) The functional evaluation of osteosarcoma patients with limb salvage treatment (in Japanese). Rinsho Seikei Geka 20: 216–226

    Google Scholar 

  2. Rosen G, Caparros B, Huvos AG, et al. (1982) Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49: 1221–1230

    Google Scholar 

  3. Winkler K, Beron G, Kotz R, et al. (1984) Neoadjuvant chemotherapy for osteogenic sarcoma: Results of a cooperative German/Austrian study. J Clin Oncol 12: 617–624

    Google Scholar 

  4. Taylor WF, Ivins JC, Unni KK, et al. (1989) Prognostic variables in osteosarcoma: A multi-institutional study. J Natl Cancer Inst 81: 21–30

    Google Scholar 

  5. Bentzen SM, Poulsen HS, Kaae S, et al. (1988) Prognostic factors in osteosarcomas. Cancer 62: 194–202

    Article  PubMed  CAS  Google Scholar 

  6. Delepine N, Delepine G, Jasmin C, et al. (1988) Importance of age and methotrexate dosage: Prognosis in children and young adults with high-grade osteosarcomas. Biomed Pharmacother 42: 257–262

    Google Scholar 

  7. Raymond AK, Chawla SP, Carrasco CH, et al. (1987) Osteosarcoma chemotherapy effects: A prognostic factor. Semin Diagn Pathol 4: 212–236

    Google Scholar 

  8. Takeyama S, Tateishi A (1989) Analysis for treatment of osteosarcoma — Good prognostic factors. J Jpn Orthop Assoc 63: S455

    Google Scholar 

  9. Scranton PE, DeCicco FA, Totten RS, et al. (1975) Prognostic factors in osteosarcoma: A review of 20 years’ experience at the University of Pittsburgh Health Center. Cancer 36: 2179–2191

    Article  PubMed  Google Scholar 

  10. Takada N, Hodaka E (1979) The treatment of osteosarcoma (in Japanese). Rinsho Seikei Geka 14: 756–764

    Google Scholar 

  11. Umeda T, Takada N, Hodaka E, et al. (1984) Evaluation of severe side effects of high-dose methotrexate in osteosarcoma (in Japanese). Gan to Kagaku Ryoho 11: 285–294

    PubMed  CAS  Google Scholar 

  12. Umeda T, Takada N, Hodaka E, et al. (1986) Toxic effects of cisplatin in the treatment of malignant bone and soft tissue tumors (in Japanese). Gan To Kagaku Ryoho 13: 1857–1861

    PubMed  CAS  Google Scholar 

  13. Takada N, Hodaka E (1979) Radiation therapy of osteosarcomas (in Japanese). Orthop Surg Traumatol 22: 681–691

    Google Scholar 

  14. Umeda T, Takada N, Seki Y (1983) The treatment of osteosarcoma patients developed pulmonary metastases (in Japanese). Rinsyo Seikei Geka 20: 917–927

    Google Scholar 

  15. Jaffe N, Spears R, Eftekhari F, et al. (1987) Pathological fracture in osteosarcoma. Cancer 59: 701–709

    Article  PubMed  CAS  Google Scholar 

  16. Wuisman P, Enneking WF (1990) Prognosis for patients who have osteosarcoma with skip metastasis. J Bone Joint Surg [Am] 72: 60–68

    CAS  Google Scholar 

  17. Rosen G, Huvos AG, Marcove R, et al. (1986) Telangiectatic osteosarcoma: Improved survival with combination chemotherapy. Clin Orthop 207: 164–173

    Google Scholar 

  18. Kawano H (1989) Neoadjuvant chemotherapy for osteosarcoma — The value in survival. J Jpn Orthop Assoc 63: S457

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Japan

About this paper

Cite this paper

Umeda, T., Ishii, T., Kitoh, M., Ozawa, T., Takada, N., Tatezaki, Si. (1992). The Evaluation of Clinical Prognostic Factors in Osteosarcomas. In: Uchida, A., Ono, K. (eds) Recent Advances in Musculoskeletal Oncology. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68364-3_27

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68364-3_27

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68366-7

  • Online ISBN: 978-4-431-68364-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics